Health
Anti-infective therapy for infections caused by drug-resistant gram-negative pathogens now in Phase I study – Outbreak News Today – Outbreak News Today
By NewsDesk @infectiousdiseasenews Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase…
By NewsDesk @infectiousdiseasenews
Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase 1 study of QPX9003, a next generation intravenous (IV)-administered synthetic polymyxin for infections caused by drug-resistant…
Continue Reading
-
General23 hours agoSearch underway for missing boat off South Australia’s Cape Jaffa
-
Noosa News23 hours agoQueensland coroner investigates ‘extremely unusual’ deaths of premature twin boys
-
Noosa News9 hours agoThe Best Things to Do in Brisbane This New Year’s Eve
-
General8 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
